Jericho Financial’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.82M Sell
26,070
-28
-0.1% -$7.18K 3.38% 14
2026
Q2
$6.57M Buy
26,098
+4,173
+19% +$898K 3.4% 15
2026
Q1
$4.77M Sell
21,925
-56
-0.3% -$12.4K 3.01% 17
2025
Q4
$5.02M Sell
21,981
-1,847
-8% -$421K 3.03% 15
2025
Q3
$5.52M Buy
23,828
+725
+3% +$148K 3.35% 13
2025
Q2
$4.29M Sell
23,103
-177
-0.8% -$32.9K 2.83% 17
2025
Q1
$4.88M Buy
23,280
+2,154
+10% +$419K 3.54% 12
2024
Q4
$3.75M Buy
+21,126
New +$3.88M 2.72% 19

Other funds holding ABBV

Jericho Financial's ABBV Position: Q3 2026 in Review

Jericho Financial reduced its AbbVie (ABBV) stake by 0.11% in Q3 2026, selling an estimated $7.18K and leaving 26,070 shares worth $6.82M. The position accounts for 3.38% of the portfolio, ranked #14.

Jericho Financial first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 2,709 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Jericho Financial held 26,070 shares of AbbVie worth $6.82M as of Q3 2026.
  • Jericho Financial sold 28 AbbVie shares in Q3 2026, an estimated $7.18K.
  • AbbVie made up 3.38% of Jericho Financial's portfolio in Q3 2026, its #14 holding.
  • Jericho Financial first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • 2,709 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Jericho Financial's 13F filing for Q3 2026, filed 13 Oct 2026.